Search research articles
Contact Us
Filters
Showing results (1-10 of 40) with videos related to
Page
of 4
Sort By:
Current Medical Research and Opinion
|
September 21, 2007
The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation
Thomas P Leist, Patrick Vermersch
The Neurologist
|
July 13, 2004
Familial multiple sclerosis and other inherited disorders of the white matter
Bernadette Kalman, Thomas P Leist
Neuromolecular Medicine
|
July 2, 2003
A mitochondrial component of neurodegeneration in multiple sclerosis
Bernadette Kalman, Thomas P Leist
Clinical Neuropharmacology
|
January 19, 2011
Cladribine: mode of action and implications for treatment of multiple sclerosis
Thomas P Leist, Robert Weissert
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
December 31, 2005
Clinical-magnetic resonance imaging correlations in multiple sclerosis
Robert Zivadinov, Thomas P Leist
Neurology
|
December 30, 2009
Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics
Thomas P Leist, Steven Marks
Health Psychology and Behavioral Medicine
|
March 21, 2022
Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability
Judith Bijoux Leist, Thomas P Leist
Journal of Neuroinflammation
|
February 26, 2005
Involvement of beta-chemokines in the development of inflammatory demyelination
Ileana Banisor, Thomas P Leist, Bernadette Kalman
Autoimmunity
|
December 17, 2002
Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration
Bernadette Kalman, Ross H Albert, Thomas P Leist
Nature Clinical Practice. Neurology
|
February 6, 2009
When metals compete: a case of copper-deficiency myeloneuropathy and anemia
Rebecca I Spain, Thomas P Leist, Eduardo A De Sousa
Page
of 4
Search research articles
Search
Showing results (1-10 of 40) with videos related to
Sort By:
Page
of 4
Current Medical Research and Opinion
|
September 21, 2007
The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation
Thomas P Leist, Patrick Vermersch
The Neurologist
|
July 13, 2004
Familial multiple sclerosis and other inherited disorders of the white matter
Bernadette Kalman, Thomas P Leist
Neuromolecular Medicine
|
July 2, 2003
A mitochondrial component of neurodegeneration in multiple sclerosis
Bernadette Kalman, Thomas P Leist
Clinical Neuropharmacology
|
January 19, 2011
Cladribine: mode of action and implications for treatment of multiple sclerosis
Thomas P Leist, Robert Weissert
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
December 31, 2005
Clinical-magnetic resonance imaging correlations in multiple sclerosis
Robert Zivadinov, Thomas P Leist
Neurology
|
December 30, 2009
Magnetic resonance imaging and treatment effects of multiple sclerosis therapeutics
Thomas P Leist, Steven Marks
Health Psychology and Behavioral Medicine
|
March 21, 2022
Multiple sclerosis: relationship between locus of control and quality of life in persons with low versus high disability
Judith Bijoux Leist, Thomas P Leist
Journal of Neuroinflammation
|
February 26, 2005
Involvement of beta-chemokines in the development of inflammatory demyelination
Ileana Banisor, Thomas P Leist, Bernadette Kalman
Autoimmunity
|
December 17, 2002
Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration
Bernadette Kalman, Ross H Albert, Thomas P Leist
Nature Clinical Practice. Neurology
|
February 6, 2009
When metals compete: a case of copper-deficiency myeloneuropathy and anemia
Rebecca I Spain, Thomas P Leist, Eduardo A De Sousa
Page
of 4